Literature DB >> 3552173

The dilemma of isolated systolic hypertension.

S B Jaglal, N H McAlister.   

Abstract

Isolated systolic hypertension, characterized by elevated systolic blood pressure (greater than 150 to 165 mm Hg), normal diastolic blood pressure (less than 90 to 95 mm Hg) and, often, atherosclerosis, is now recognized as an important risk factor for cardiovascular disease. When the systolic pressure is 200 mm Hg or greater, or when it is 180 mm Hg or greater and accompanied by target organ damage, therapeutic intervention may be of value in patients under the age of 80 years. Low doses of thiazide diuretics have been shown to be safe and effective in lowering the systolic pressure. If the blood pressure remains high, treatment with methyldopa may be added.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3552173      PMCID: PMC1492165     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  25 in total

1.  Recommendations from the Consensus Conference on Hypertension in the Elderly.

Authors:  P Larochelle; M J Bass; N J Birkett; J De Champlain; M G Myers
Journal:  CMAJ       Date:  1986-10-01       Impact factor: 8.262

Review 2.  Clinical significance and management of systolic hypertension.

Authors:  R C Tarazi; R W Gifford
Journal:  Cardiovasc Clin       Date:  1978

3.  Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; M J Schwartz
Journal:  Am J Cardiol       Date:  1971-04       Impact factor: 2.778

4.  Perspectives on systolic hypertension. The Framingham study.

Authors:  W B Kannel; T R Dawber; D L McGee
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

5.  Should you treat systolic hypertension in the diabetic?

Authors:  A R Christlieb
Journal:  Geriatrics       Date:  1979-11

6.  Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures.

Authors:  S W Rabkin; A L Mathewson; R B Tate
Journal:  Ann Intern Med       Date:  1978-03       Impact factor: 25.391

7.  Hazards in treatment of systolic hypertension.

Authors:  Y M Traub; M M Aygen; J B Rosenfeld
Journal:  Am Heart J       Date:  1979-02       Impact factor: 4.749

8.  Systolic hypertension: occurrence and treatment in a defined community.

Authors:  A W Seligmann; M H Alderman; T K Davis
Journal:  J Am Geriatr Soc       Date:  1979-03       Impact factor: 5.562

9.  Systolic hypertension: hemodynamic mechanism and choice of antihypertensive treatment.

Authors:  A C Simon; M A Safar; J A Levenson; A M Kheder; B I Levy
Journal:  Am J Cardiol       Date:  1979-09       Impact factor: 2.778

10.  Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study.

Authors:  W B Kannel; P A Wolf; D L McGee; T R Dawber; P McNamara; W P Castelli
Journal:  JAMA       Date:  1981-03-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.